Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 7
1988 3
1989 4
1990 2
1991 8
1992 3
1993 5
1994 2
1995 3
1996 2
1997 3
1999 7
2000 1
2001 2
2002 4
2003 1
2004 1
2005 4
2006 4
2007 1
2008 2
2009 2
2010 3
2011 5
2012 2
2013 5
2014 6
2015 9
2016 10
2017 8
2018 3
2019 6
2020 9
2021 5
2022 4
2023 4
2024 2
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
Piselli P, Tavelli A, Cimaglia C, Muccini C, Bandera A, Marchetti GC, Torti C, Mazzotta V, Pipitò L, Caioli A, Girardi E, Antinori A, Serraino D, d'Arminio Monforte A, Cingolani A; Icona Foundation Study Group. Piselli P, et al. Int J Cancer. 2025 Sep 15;157(6):1142-1153. doi: 10.1002/ijc.35493. Epub 2025 May 29. Int J Cancer. 2025. PMID: 40437996 Free PMC article.
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Mussini C, Giacomelli A, Quiros-Roldan E, Mazzotta V, Di Biagio A, De Vito A, Costantini A, D'Ettorre G, Giacometti A, Vergori A, Tavelli A, Malagnino V, Castagna A, Chester J, Antinori A, d'Arminio Monforte A, Cozzi-Lepri A; Icona Foundation Cohort Study for the Icona Foundation Study Group. Mussini C, et al. EClinicalMedicine. 2025 Jul 24;86:103368. doi: 10.1016/j.eclinm.2025.103368. eCollection 2025 Aug. EClinicalMedicine. 2025. PMID: 40740293 Free PMC article.
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort.
Gagliardini R, De Benedittis S, Tavelli A, Lapadula G, Mazzotta V, Bruzzesi E, Cervo A, Carrozzo G, Saracino A, Rusconi S, Marchetti G, Ceccherini-Silberstein F, Antinori A, d'Arminio Monforte A, Muccini C; Icona Foundation Study Group. Gagliardini R, et al. J Antimicrob Chemother. 2025 Aug 1;80(8):2169-2178. doi: 10.1093/jac/dkaf184. J Antimicrob Chemother. 2025. PMID: 40570134 Free PMC article.
Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort.
De Vito A, Tavelli A, Cozzi-Lepri A, Giacomelli A, Rossotti R, Ponta G, Bobbio N, Ianniello A, Cingolani A, Madeddu G, Antinori A, d'Arminio Monforte A; ICONA Foundation Study Group. De Vito A, et al. HIV Med. 2025 Jun;26(6):970-977. doi: 10.1111/hiv.70037. Epub 2025 Apr 28. HIV Med. 2025. PMID: 40296167 Free PMC article.
Silent HIV infection.
Aiuti F, Ensoli F, Fiorelli V, Mezzaroma I, Pinter E, Guerra E, Varani AR. Aiuti F, et al. Among authors: mezzaroma i. Vaccine. 1993;11(5):538-41. doi: 10.1016/0264-410x(93)90226-n. Vaccine. 1993. PMID: 8488706
Dolutegravir: clinical efficacy and role in HIV therapy.
Fantauzzi A, Mezzaroma I. Fantauzzi A, et al. Among authors: mezzaroma i. Ther Adv Chronic Dis. 2014 Jul;5(4):164-77. doi: 10.1177/2040622314530461. Ther Adv Chronic Dis. 2014. PMID: 24982751 Free PMC article. Review.
Th2-type cytokines, hypereosinophilia, and interleukin-5 in HIV disease.
Paganelli R, Scala E, Mazzone AM, Rosso R, Mattiacci G, Dell'Anna L, Mezzaroma I, Aiuti F. Paganelli R, et al. Among authors: mezzaroma i. Allergy. 1997 Jan;52(1):110-1. doi: 10.1111/j.1398-9995.1997.tb02555.x. Allergy. 1997. PMID: 9062639 Review. No abstract available.
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.
Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L. Michelini Z, et al. Among authors: mezzaroma i. HIV Clin Trials. 2016 Mar;17(2):49-54. doi: 10.1080/15284336.2015.1125077. Epub 2016 Jan 7. HIV Clin Trials. 2016. PMID: 26739837 Clinical Trial.
150 results